DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Bernard Orr Brenda Goh"


2 mentions found


☆ China defends its retaliation against South Korea, Japan COVID curbs
  + stars: | 2023-01-11 | by ( Bernard Orr Brenda Goh | Bernard Orr | Brenda Goh | ) www.reuters.com   time to read: +5 min
REUTERS/Tingshu WangBEIJING, Jan 11 (Reuters) - Chinese state media defended on Wednesday the retaliatory measures against South Korea and Japan over their COVID-19 travel curbs as "reasonable", while Chinese tourists decried Seoul's "insulting" treatment on social media. South Korea, Japan, the United States and more than a dozen other countries imposed at the start of the year requirements for pre-departure negative test results from visitors from China. 'INSULTING'Chinese social media anger mainly targeted South Korea, whose border measures are the strictest among the countries that announced new rules. Global Times reserved a separate article for South Korea, saying the measures made Chinese people suspicious that Seoul was putting up a "political show." Annual spending by Chinese tourists abroad reached $250 billion before the pandemic, with South Korea and Japan among the top shopping destinations.
☆ China urges vaccines for vulnerable as 'zero-COVID' exit turns messy
  + stars: | 2022-12-15 | by ( Bernard Orr Brenda Goh | Bernard Orr | Brenda Goh | ) www.reuters.com   time to read: +6 min
[1/2] People line up next to a medical worker in a protective suit, at a fever clinic of a hospital amid the coronavirus disease (COVID-19) outbreak in Beijing, China December 15, 2022. The pivot away from President Xi Jinping's signature "zero-COVID" policy followed unprecedented widespread protests against it. But, WHO emergencies director Mike Ryan said COVID-19 infections were exploding in China well before the government's decision to phase out its stringent regime. There are increasing signs of chaos during China's exit from the zero-COVID policy - with long queues outside fever clinics, runs on medicines, and panic buying across the country. China Meheco Group Co Ltd (600056.SS) said on Wednesday it signed a deal to import the U.S. drugmaker's treatment.
0 next >>
Total: 2